NEW YORK (AP) 鈥� NEW YORK (AP) 鈥� Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $64.5 million in its first quarter.
On a per-share basis, the New York-based company said it had a loss of $1.26.
The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 85 cents per share.
The biopharmaceutical company posted revenue of $191.2 million in the period, surpassing Street forecasts. Eight analysts surveyed by Zacks expected $189.2 million.
Axsome shares have risen 13% since the beginning of the year. The stock has increased 84% in the last 12 months.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/AXSM
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
